Hainan Poly Pharm.Co.,Ltd.’s Net Profit Rose 16.7% in First Three Quarters of 2022

Hainan Poly Pharm.Co.,Ltd. (海南普利制药股份有限公司) (300630.SZ) reported a net profit of 455.5 million yuan in the first three quarters of 2022, up 16.7% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, up 20.6% year-on-year.

At the end of the reporting period, it had 5.6 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 48.9%.